The Oncology Nurse
  • Home
  • Categories
  • Issues
    • 2018
      • November 2018 - Vol 11 No 5
      • September 2018 - Vol 11 No 4
      • July 2018 - Vol 11 No 3
      • May 2018 - Vol 11 No 2
      • March 2018 - Vol 11 No 1
    • 2017
      • November 2017 - Vol 10 No 6
      • September 2017 - Vol 10 No 5
      • July 2017 - Vol 10 No 4
      • May 2017 - Vol 10 No 3
      • March Vol 10 No 2
      • January Vol 10 No 1
    • 2016
      • November Vol 9 No 6
      • September Vol 9 No 5
      • July Vol 9 No 4
      • May Vol 9 No 3
      • March Vol 9 No 2
      • January Vol 9 No 1
    • Issue Archive
    • Special Issues
      • 2018 Guide to New FDA Approvals
  • Media Library
    • Video Library
      • TON Interview with the Innovators Series
    • Audiocast Library
  • News
    • In the News
    • Press Releases
    • Conference Correspondent
      • ESMO 2018
        • ESMO 2018 Wrap-Up
      • HNF 2018
      • ASH 2017 - ITP
      • SABCS 2017 - Breast Cancer
      • ONS 2017 - Immunotherapy
      • ASH 2016 - Roundup
      • ASH 2016 - Multiple Myeloma
      • ASH 2015 - Multiple Myeloma
  • CE
  • Resource
    • Online Only
  • Supplements
  • Quick Quiz
  • About
    • Contact Us
    • Editorial Board
    • Advertise
  • Submit
    • Author Guidelines
The Oncology Nurse

Loretta Fala, Medical Writer

Authored Items
Kymriah (Tisagenlecleucel) for Young Patients with Acute Lymphoblastic Leukemia: First FDA-Approved Gene Therapy
Loretta Fala, Medical Writer
2018 Third Annual Oncology Guide to New FDA Approvals in FDA Approvals, News & Updates, Leukemia
Verzenio (Abemaciclib) a New CDK4/CDK6 Inhibitor Approved for HR-Positive, HER2-Negative Advanced or Metastatic Breast Cancer
Loretta Fala, Medical Writer
2018 Third Annual Oncology Guide to New FDA Approvals in FDA Approvals, News & Updates, Breast Cancer
Yescarta (Axicabtagene Ciloleucel) Second CAR T-Cell Therapy Approved for Patients with Certain Types of Large B-Cell Lymphoma
Loretta Fala, Medical Writer
2018 Third Annual Oncology Guide to New FDA Approvals in FDA Approvals, News & Updates, Lymphoma
Lartruvo (Olaratumab) a Novel First-Line Treatment Approved for Patients with Advanced Soft-Tissue Sarcoma
Loretta Fala, Medical Writer
2017 Oncology Pharmacy Guide to New FDA Approvals in Drug Profiles
Portrazza (Necitumumab), an IgG1 Monoclonal Antibody, FDA Approved for Advanced Squamous Non–Small-Cell Lung Cancer
Loretta Fala, Medical Writer
2016 Oncology Pharmacy Guide to New FDA Approvals in Drug Profiles
Last modified: May 12, 2016
Sign Up Now!
To sign up for our newsletter or print publications, enter your contact information below.
First Name
Last Name
Address
Address (Continued)
City
State/Province
ZIP/Postal Code
Country
  • Privacy Policy
  • Terms of Use
  • Home
  • About
  • Subscribe
  • Advertise
  • Contact Us

©2019 Green Hill Healthcare Communications, LLC, an affiliate of The Lynx Group. All rights reserved.
1249 South River Road - Suite 202, Cranbury, NJ 08512

  • Home
  • Categories
  • Issues
    • 2018
      • November 2018 - Vol 11 No 5
      • September 2018 - Vol 11 No 4
      • July 2018 - Vol 11 No 3
      • May 2018 - Vol 11 No 2
      • March 2018 - Vol 11 No 1
    • 2017
      • November 2017 - Vol 10 No 6
      • September 2017 - Vol 10 No 5
      • July 2017 - Vol 10 No 4
      • May 2017 - Vol 10 No 3
      • March Vol 10 No 2
      • January Vol 10 No 1
    • 2016
      • November Vol 9 No 6
      • September Vol 9 No 5
      • July Vol 9 No 4
      • May Vol 9 No 3
      • March Vol 9 No 2
      • January Vol 9 No 1
    • Issue Archive
    • Special Issues
      • 2018 Guide to New FDA Approvals
  • Media Library
    • Video Library
      • TON Interview with the Innovators Series
    • Audiocast Library
  • News
    • In the News
    • Press Releases
    • Conference Correspondent
      • ESMO 2018
        • ESMO 2018 Wrap-Up
      • HNF 2018
      • ASH 2017 - ITP
      • SABCS 2017 - Breast Cancer
      • ONS 2017 - Immunotherapy
      • ASH 2016 - Roundup
      • ASH 2016 - Multiple Myeloma
      • ASH 2015 - Multiple Myeloma
  • CE
  • Resource
    • Online Only
  • Supplements
  • Quick Quiz
  • About
    • Contact Us
    • Editorial Board
    • Advertise
  • Submit
    • Author Guidelines